Tadalafil in Subjects With Mild to Moderate Hypertension
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Purpose: The primary objective of this study is to evaluate the efficacy and safety of
tadalafil when administered once daily at doses of 5 and 20 mg to adult subjects for 8 weeks
with mild to moderate hypertension.